{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-data-sharing-transparency-in-public-health-emergencies”
},
“headline”: “SOP for Data Sharing/Transparency in Public Health Emergencies”,
“description”: “This SOP establishes procedures for data sharing and transparency in clinical trials conducted during public health emergencies. It ensures compliance with WHO expectations, ethical imperatives, and rapid dissemination of data for global health protection.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}
Published on 21/12/2025
Standard Operating Procedure for Data Sharing/Transparency in Public Health Emergencies
| SOP No. | CR/OPS/153/2025 |
| Supersedes | NA |
| Page No. | X of Y |
| Issue Date | 26/08/2025 |
| Effective Date | 01/09/2025 |
| Review Date | 01/09/2026 |
Purpose
The purpose of this SOP is to establish structured procedures for timely data sharing and transparency in clinical trials conducted during public health emergencies
Scope
This SOP applies to sponsors, CROs, investigators, regulatory affairs teams, and data managers involved in trials conducted during emergencies. It covers trial registration, expedited data sharing, publication requirements, and communication with regulators, WHO, and the public.
Responsibilities
- Sponsor: Ensures timely data release to WHO and national authorities.
- CRO: Facilitates operational aspects of emergency data sharing.
- Investigator: Ensures accurate and real-time reporting of trial data.
- Regulatory Affairs: Coordinates communication with health authorities and WHO.
- QA: Audits emergency data sharing records for compliance.
Accountability
The Sponsor’s Regulatory and Clinical Heads are accountable for ensuring that trial data are rapidly and transparently shared with global health authorities during emergencies.
Procedure
1. Trial Registration
1.1 Register trial in WHO ICTRP-recognized registry prior to enrollment.
1.2 Ensure registry updates every 30 days.
1.3 Document in Trial Registration Log (Annexure-1).
2. Interim Data Sharing
2.1 Submit interim safety and efficacy results to WHO and regulators within agreed timelines.
2.2 Share aggregated anonymized data with public health stakeholders.
2.3 Record in Interim Data Sharing Log (Annexure-2).
3. Final Results Disclosure
3.1 Publish trial results within 6 months of study completion in open-access platforms.
3.2 Notify WHO and regulators of data availability.
3.3 Document in Final Results Disclosure Log (Annexure-3).
4. Communication
4.1 Provide regular updates to trial participants and affected communities.
4.2 Maintain transparency through press releases, websites, or public dashboards.
4.3 Document in Communication Log (Annexure-4).
5. Archiving
5.1 Archive shared data, communications, and reports in TMF and ISF.
5.2 Record details in Data Archiving Log (Annexure-5).
Abbreviations
- SOP: Standard Operating Procedure
- WHO: World Health Organization
- ICTRP: International Clinical Trials Registry Platform
- CRO: Contract Research Organization
- QA: Quality Assurance
- TMF: Trial Master File
- ISF: Investigator Site File
Documents
- Trial Registration Log (Annexure-1)
- Interim Data Sharing Log (Annexure-2)
- Final Results Disclosure Log (Annexure-3)
- Communication Log (Annexure-4)
- Data Archiving Log (Annexure-5)
References
Version: 1.0
Approval Section
| Prepared By | Ravi Kumar, Regulatory Affairs Specialist |
| Checked By | Sunita Reddy, QA Officer |
| Approved By | Dr. Anil Sharma, Head Clinical Operations |
Annexures
Annexure-1: Trial Registration Log
| Date | Registry | Protocol ID | Registered By | Status |
|---|---|---|---|---|
| 01/09/2025 | CTRI | PHE-2025-01 | Reg Affairs | Registered |
Annexure-2: Interim Data Sharing Log
| Date | Data Shared | Recipient | Shared By | Status |
|---|---|---|---|---|
| 05/09/2025 | Safety Data | WHO | PV Officer | Submitted |
Annexure-3: Final Results Disclosure Log
| Date | Results Published | Platform | Submitted By | Status |
|---|---|---|---|---|
| 15/09/2025 | Trial Report | Open Access Journal | Sponsor | Completed |
Annexure-4: Communication Log
| Date | Audience | Communication Type | By | Status |
|---|---|---|---|---|
| 10/09/2025 | Community | Public Meeting | Investigator | Completed |
Annexure-5: Data Archiving Log
| Date | Data Type | Archived By | Location | Status |
|---|---|---|---|---|
| 20/09/2025 | Safety & Results | QA | TMF | Archived |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 26/08/2025 | 00 | Initial version | New SOP creation | Head Clinical Operations |
For more SOPs visit: Pharma SOP
